From the Editor

Can we reduce the use of abdominal hysterectomy and increase the use of vaginal and laparoscopic approaches?

Author and Disclosure Information

Too many hysterectomies are performed using a laparotomy incision. Increasing the use of vaginal and laparoscopic hysterectomy will improve surgical outcomes for US women.


 

References

Hysterectomy for benign disease is a very effective operation to treat moderate to severe uterine bleeding or pain caused by uterine problems. There are 3 main surgical approaches to performing a hysterectomy: vaginal, laparoscopic, and abdominal.

“Abdominal hysterectomy” is a term that indicates the procedure was performed using a relatively large incision in the abdominal wall. It also is possible for 2 surgical routes to be combined into one operation, such as a laparoscopically assisted vaginal hysterectomy or a laparoscopic hysterectomy with a mini-laparotomy incision to remove the uterus.

Substantial evidence indicates that vaginal and laparoscopic approaches to hysterectomy result in superior outcomes when compared with abdominal hysterectomy. In this editorial I highlight that data, as well as offer concrete ways in which we can increase the use of vaginal and laparoscopic hysterectomy while reducing the current reliance on an abdominal approach.

Vaginal and laparoscopic hysterectomy are associated with more rapid recoveryAuthors of a meta-analysis of 
47 randomized trials involving 
5,102 women concluded that women who underwent vaginal and laparoscopic hysterectomy had faster return to full activity, compared with women who had an abdominal hysterectomy. Compared with vaginal hysterectomy, the abdominal 
 approach required an additional 
12 days of postoperative recovery before return to normal activities and 
1 additional day of postoperative hospitalization.1

In the same meta-analysis, when compared with the laparoscopic approach, abdominal hysterectomy required 15 additional days to return to normal activity and 2.6 more days of postoperative hospitalization.1 The evidence indicates that to maximize rapid return of the patient to full activity, we should reduce the use of abdominal hysterectomy for benign disease.

Abdominal hysterectomy is the most frequent US surgical approach In the United States in 2010, the rates of hysterectomy by route were 56% abdominal, 25% laparoscopic, and 19% vaginal.2 In contrast to US practice, French, German, and Australian gynecologists prioritize the vaginal route. In France in 2004, the rates of hysterectomy by route were 48% vaginal, 27% laparoscopic, and 25% abdominal.3 In Australia and Germany, vaginal hysterectomy is performed in 39% and 55% of all hysterectomy cases, respectively—a greater rate of vaginal hysterectomy than observed in the United States (TABLE 1).4,5

Our goal should be 40% or less 
for abdominal hysterectomy. 
Based on the experience of French,3 
Australian,4 and German5 surgeons, a realistic goal is to reduce the use of abdominal hysterectomy in the United States to a rate of 40% or less and to increase the use of vaginal and laparoscopic hysterectomy to a combined rate of 60% or more.

Perceived contraindications for vaginal hysterectomy may not be valid

Surgeons may avoid selecting a vaginal route for hysterectomy for benign uterine disease when the patient has a markedly enlarged uterus (for example, >16 weeks’ size) or a markedly enlarged cervix or lower uterine segment. The large uterus may be difficult to remove through the vagina and an enlarged cervix or lower uterine segment may make it difficult to enter the peritoneal cavity.

However, large uteri can be removed through the vagina using uterine reduction techniques, including uterine bisection and intramyometrial coring. In one randomized clinical trial,1 women with enlarged uteri were randomly assigned to vaginal or abdominal hysterectomy. Both approaches were successful in removing large uteri. When compared with abdominal hysterectomy, the vaginal approach was associated with shorter operative time, less postoperative fever, less postoperative pain, and fewer hospital days following surgery.

Reference

1. Benassi L, Rossi T, Kaihura CT, et al. Abdominal or vaginal hysterectomy for enlarged uteri: a randomized clinical trial. Am J Obstet Gynecol. 2002;187(6):1561–1565.

How will we increase vaginal and laparoscopic hysterectomy for benign disease?In order to reduce the use of abdominal hysterectomy, a multipronged effort is needed:

  • Leaders in gynecology need to champion the use of vaginal and laparoscopic hysterectomy.
  • Educators in gynecology need to refocus and intensify surgical training to ensure that trainees are confident in their ability to perform both vaginal and laparoscopic hysterectomy.
  • Hospital departments need to provide the continuing education and senior surgical mentoring that will facilitate reducing the use of abdominal hysterectomy.
  • Quality review committees need to review the indication for abdominal hysterectomy procedures and question whether they could be better performed by a vaginal or laparoscopic route.

AAGL launches comprehensive video cooperative. A major new educational video offering on vaginal hysterectomy recently was released by the AAGL (TABLE 2).
 Produced by the AAGL and cosponsored by the American College 
of Obstetricians and Gynecologists 
and the Society of Gynecologic 
Surgeons, this resource includes detailed videos focused on basic instrumentation and technique, techniques for adnexal surgery at vaginal hysterectomy, and managing
 complications. I believe this resource will be of great value as momentum builds to increase the use of vaginal hysterectomy. In addition, OBG Management will continue to publish major articles by 
leading surgeons focused on vaginal hysterectomy.

Pages

Recommended Reading

Menopause status could guide breast cancer screening interval
MDedge ObGyn
American Cancer Society recommends annual mammography starting at age 45
MDedge ObGyn
DenseBreast-info.org: What this resource can offer you, and your patients
MDedge ObGyn
Managing menopausal symptoms after risk-reducing salpingo-oophorectomy
MDedge ObGyn
What you should know about the latest change in mammography screening guidelines
MDedge ObGyn
What does Liletta cost 
to non-340B providers?
MDedge ObGyn
What you need to know (and do) to prescribe the new drug flibanserin
MDedge ObGyn
How to individualize cancer risk reduction after a diagnosis of DCIS
MDedge ObGyn
Signs of chorioamnionitis ignored? $3.5M settlement
MDedge ObGyn
Salpingectomy after vaginal hysterectomy: Technique, tips, and pearls
MDedge ObGyn

Related Articles